Journal Scan

Ifosfamide safe via continuous infusion in kids with Ewing sarcoma

Continuous infusion of the antitumor agent ifosfamide appears safe and feasible for use in an outpatient setting in pediatric patients with Ewing sarcoma, according to a study. The way ifosfamide is administered can affect its therapeutic and toxic effects. In this single-center, retrospective review, 10 pediatric patients with Ewing sarcoma...